• Wed news: Gilead HIV pipeline. Walgreens may go private. How Trump 2.0 will affect medtech. Lilly to offer Zepbound via Ro Telehealth. Pharma’s regulatory optimism. See more on our front page

Generic cerenia



















which would be a big concern if it wasn’t just a rounding error on the bottom line

Don't get too excited its a small piece of the pie, and they’ve been jacking up the price on it for years…. don’t forget they are ramping up their Amazon and over-the-counter retail teams to sell more outside of the veterinary hospitals. A competitive product to Apoquel would have a big impact...